The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key markets has introduced significant volatility. Investors are now assessing the effect of rival medications